Skip to content
GraphTheory.in
h-index
39

via OpenAlex

Citations
6,656

via OpenAlex

Publications
340

About

Prof. Tarun Jha, a faculty member of Dept. of Pharmaceutical Technology, Jadavpur University, has supervised eight PhD students and guided five research projects funded by different organizations. He has published more than 90 research articles in different reputed journals. His research area includes designing and synthesis of anticancer small molecules. He is one of the E.C. members of National Board of Accreditation (NBA), New Delhi, India.

Research areas

  • Chemistry
  • Medicine
  • Biology
  • Stereochemistry
  • Biochemistry

Publications (340)

Sorted by most cited.

  1. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview

    European Journal of Medicinal Chemistry1970journal article

    View DOI
    576 cites
  2. HDAC6 as privileged target in drug discovery: A perspective

    Pharmacological Research1970journal article

    View DOI
    243 cites
  3. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents

    Journal of Medicinal Chemistry1970journal article

    View DOI
    128 cites
  4. Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review

    European Journal of Medicinal Chemistry1970journal article

    View DOI
    117 cites
  5. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies

    2021

    View DOI
    115 cites
  6. 110 cites
  7. Fight against novel coronavirus: A perspective of medicinal chemists

    European Journal of Medicinal Chemistry1970journal article

    View DOI
    79 cites
  8. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview

    European Journal of Medicinal Chemistry1970journal article

    View DOI
    65 cites
  9. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy

    2021

    View DOI
    62 cites
  10. Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery

    2021

    View DOI
    57 cites
  11. Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer

    2023

    View DOI
    53 cites
  12. Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches

    2023

    View DOI
    46 cites
  13. An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches

    2024

    View DOI
    44 cites
  14. Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer

    2022

    View DOI
    43 cites
  15. QSAR study on some pyridoacridine ascididemin analogues as anti-tumor agents

    Bioorganic and Medicinal Chemistry1970journal article

    View DOI
    41 cites
  16. 41 cites
  17. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences

    2022

    View DOI
    38 cites
  18. 36 cites
  19. Chrysin-loaded PLGA attenuates OVA-induced allergic asthma by modulating TLR/NF-κB/NLRP3 axis

    Nanomedicine: Nanotechnology, Biology, and Medicine1970journal article

    View DOI
    36 cites
  20. Anthocephaline, a New Indole Alkaloid and Cadambine, a Potent Inhibitor of DNA Topoisomerase IB of <i>Leishmania donovani</i> (LdTOP1LS), Isolated from <i>Anthocephalus cadamba</i>

    2015

    View DOI
    35 cites
  21. Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors

    2021

    View DOI
    33 cites
  22. A review on camptothecin analogs with promising cytotoxic profile

    Anti-Cancer Agents in Medicinal Chemistry1970journal article

    View DOI
    32 cites
  23. Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development

    2022

    View DOI
    30 cites
  24. Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

    2021

    View DOI
    29 cites
  25. Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model

    2021

    View DOI
    28 cites
  26. Hot nuclear matter in asymmetry chiral sigma model

    Nuclear Physics A1970journal article

    View DOI
    28 cites
  27. Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?

    2023

    View DOI
    27 cites
  28. Selective Inhibitors of Medium-Size S1′ Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery

    2022

    View DOI
    27 cites
  29. 27 cites
  30. Designing potential HDAC3 inhibitors to improve memory and learning

    Journal of Biomolecular Structure and Dynamics1970journal article

    View DOI
    27 cites
  31. Selective and nonselective HDAC8 inhibitors: a therapeutic patent review

    Pharmaceutical patent analyst1970journal article

    View DOI
    27 cites
  32. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents

    European Journal of Medicinal Chemistry1970journal article

    View DOI
    26 cites
  33. Quantitative structural assessments of potential meprin β inhibitors by non-linear QSAR approaches and validation by binding mode of interaction analysis

    2023

    View DOI
    25 cites
  34. Attributes of a rotating neutron star with a hyperon core

    Physical Review C - Nuclear Physics1970journal article

    View DOI
    25 cites
  35. Antibacterial activity of Abies webbiana

    Fitoterapia1970journal article

    View DOI
    25 cites
  36. A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design

    2022

    View DOI
    24 cites
  37. 24 cites
  38. Density functional theory (DFT) studies in HDAC-based chemotherapeutics: Current findings, case studies and future perspectives

    2024

    View DOI
    22 cites
  39. Exploring sodium glucose cotransporter (SGLT2) inhibitors with machine learning approach: A novel hope in anti-diabetes drug discovery

    2021

    View DOI
    22 cites
  40. Ligand-based Design of Anticancer MMP2 Inhibitors: a Review

    2021

    View DOI
    22 cites
  41. Recent trends in fragment-based anticancer drug design strategies against different targets: A mini-review

    2022

    View DOI
    21 cites
  42. Bulk viscosity in a hyperonic star and r-mode instability

    Physical Review C - Nuclear Physics1970journal article

    View DOI
    21 cites
  43. 21 cites
  44. Constraints on nuclear matter parameters of an effective chiral model

    Physical Review C - Nuclear Physics1970journal article

    View DOI
    21 cites
  45. 21 cites
  46. 21 cites
  47. Synthesis, biological assessment, and in silico binding mode interaction analyses and DFT studies of biphenylsulfonamide-based potent MMP-2 inhibitors effective against chronic myeloid leukemia

    2024

    View DOI
    19 cites
  48. Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences

    2021

    View DOI
    19 cites
  49. Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE2)

    2021

    View DOI
    19 cites
  50. A New Ellagic Acid Glycoside and DNA Topoisomerase IB Inhibitory Activity of Saponins from <i>Putranjiva roxburghii</i>

    2014

    View DOI
    19 cites
  51. Neutron star matter in an effective model

    Physical Review C - Nuclear Physics1970journal article

    View DOI
    19 cites
  52. Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis

    2024

    View DOI
    18 cites
  53. Hyperon bulk viscosity and <i>r</i>-modes of neutron stars

    2022

    View DOI
    18 cites
  54. How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors

    2021

    View DOI
    17 cites
  55. Urea transporter and its specific and nonspecific inhibitors: State of the art and pharmacological perspective

    2021

    View DOI
    17 cites
  56. An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present)

    2023

    View DOI
    16 cites
  57. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors – Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies – First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together

    2021

    View DOI
    16 cites
  58. Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CL<sup>pro</sup> inhibitors: theoretical justification in light of experimental evidences

    2021

    View DOI
    16 cites
  59. Quantitative activity–activity relationship (QAAR) driven design to develop hydroxamate derivatives of pentanoic acids as selective HDAC8 inhibitors: synthesis, biological evaluation and binding mode of interaction studies

    2021

    View DOI
    16 cites
  60. Quantitative Structure-Activity Relationship Study on Some Azidopyridinyl Neonicotinoid Insecticides for Their Selective Affinity Towards the Drosophila Nicotinic Receptor Over Mammalian a4ß2 Receptor Using Electrotopological State Atom Index

    2003

    View DOI
    16 cites
  61. Towards the Development of Anticancer Drugs from Andrographolide: Semisynthesis, Bioevaluation, QSAR Analysis and Pharmacokinetic Studies

    2015

    View DOI
    15 cites
  62. 15 cites
  63. 15 cites
  64. 15 cites
  65. A combined ligand-based and structure-based <i>in silico</i> molecular modeling approach to pinpoint the key structural attributes of hydroxamate derivatives as promising meprin β inhibitors

    2024

    View DOI
    14 cites
  66. Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery

    2021

    View DOI
    14 cites
  67. An overview of matrix metalloproteinase-12 in multiple disease conditions, potential selective inhibitors, and drug designing strategies

    2024

    View DOI
    13 cites
  68. Biphenylsulfonamides as effective MMP‐2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis

    2024

    View DOI
    13 cites
  69. A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013–present)

    2024

    View DOI
    13 cites
  70. Derivatives of D(−) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis

    2024

    View DOI
    13 cites
  71. The first report on predictive comparative ligand-based multi-QSAR modeling analysis of 4-pyrimidinone and 2-pyridinone based APJ inhibitors

    2022

    View DOI
    13 cites
  72. Quantitative structure activity relationship (QSAR) studies of some substituted benzenesulphonyl glutamines as tumour suppressors.

    2001

    13 cites
  73. 13 cites
  74. Histone deacetylase 8 in focus: Decoding structural prerequisites for innovative epigenetic intervention beyond hydroxamates

    2024

    View DOI
    12 cites
  75. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design

    2024

    View DOI
    12 cites
  76. Matrix metalloproteinase-8 (MMP-8) and its inhibitors: A minireview

    2024

    View DOI
    12 cites
  77. Fragment-based structural exploration and chemico-biological interaction study of HDAC3 inhibitors through non-linear pattern recognition, chemical space, and binding mode of interaction analysis

    2023

    View DOI
    12 cites
  78. Binary quantitative activity-activity relationship (QAAR) studies to explore selective HDAC8 inhibitors: In light of mathematical models, DFT-based calculation and molecular dynamic simulation studies

    2022

    View DOI
    12 cites
  79. Applying comparative molecular modelling techniques on diverse hydroxamate-based HDAC2 inhibitors: an attempt to identify promising structural features for potent HDAC2 inhibition

    2022

    View DOI
    12 cites
  80. Shape change in Hf, W and Os-isotopes: A non-relativistic Hartree-Fock versus relativistic Hartree approximation

    2004

    View DOI
    12 cites
  81. A relativistic mean-field study of magic numbers in light nuclei from neutron to proton drip-lines

    2003

    View DOI
    12 cites
  82. Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies

    2024

    View DOI
    11 cites
  83. Fragment-based investigation of thiourea derivatives as VEGFR-2 inhibitors: a cross-validated approach of ligand-based and structure-based molecular modeling studies

    2023

    View DOI
    11 cites
  84. Erratum: Neutron star matter in an effective model (Phys. Rev. C (2006) 74 (055803))

    Physical Review C - Nuclear Physics1970journal article

    View DOI
    11 cites
  85. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents

    2024

    View DOI
    10 cites
  86. A fragment-based structural analysis of MMP-2 inhibitors in search of meaningful structural fragments

    2022

    View DOI
    10 cites
  87. First molecular modelling report on tri-substituted pyrazolines as phosphodiesterase 5 (PDE5) inhibitors through classical and machine learning based multi-QSAR analysis

    2021

    View DOI
    10 cites
  88. Synthesis, biological activity, structure activity relationship study and liposomal formulation development of some arylsulfonyl pyroglutamic acid derivatives

    2021

    View DOI
    10 cites
  89. 10 cites
  90. A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches

    2022

    View DOI
    9 cites
  91. A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors

    2022

    View DOI
    9 cites
  92. Synthesis, Anticancer Activity, SAR and Binding Mode of Interaction Studies of Substituted Pentanoic Acids: Part II

    2021

    View DOI
    9 cites
  93. A robust classification-dependent multi-molecular modelling study on some biphenyl sulphonamide based MMP-8 inhibitors

    2021

    View DOI
    9 cites
  94. Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy

    2002

    9 cites
  95. Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) and pharmacophore modeling

    2024

    View DOI
    8 cites
  96. Modeling Inhibitors of Matrix Metalloproteinases

    2023

    View DOI
    8 cites
  97. Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition

    2023

    View DOI
    8 cites
  98. Hydrazides as Potential HDAC Inhibitors: Structure-activityRelationships and Biological Implications

    2023

    View DOI
    8 cites
  99. Exploration of structural alerts and fingerprints for novel anticancer therapeutics: a robust classification-QSAR dependent structural analysis of drug-like MMP-9 inhibitors

    2023

    View DOI
    8 cites
  100. A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors

    2022

    View DOI
    8 cites
  101. Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery

    2021

    View DOI
    8 cites
  102. Possible antineoplastic agents: Part XIII. Synthesis, biological evaluation and QSAR studies of some 1-(substituted benzenesulphonyl)-5-oxopyrrolidine-2-carboxylic acid derivatives.

    1993

    8 cites
  103. Ligand-and structure-based drug design of non-steroidal aromatase inhibitors (NSAIs) in breast cancer

    Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment1970book

    View DOI
    8 cites
  104. Collagenases and gelatinases and their inhibitors as anticancer agents

    Cancer-Leading Proteases: Structures, Functions, and Inhibition1970book chapter

    View DOI
    8 cites
  105. Intermolecular association of some selected melanin monomers and their optical absorption

    Computational and Theoretical Chemistry1970journal article

    View DOI
    8 cites
  106. Derivatives of D(−)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis

    2024

    View DOI
    7 cites
  107. Antitumor Activity and Antioxidant Role of Ichnocarpus frutescens Against Ehrlich Ascites Carcinoma in Swiss Albino Mice

    2007

    7 cites
  108. A critical analysis of urea transporter B inhibitors: molecular fingerprints, pharmacophore features for the development of next-generation diuretics

    2022

    View DOI
    6 cites
  109. Predictive Comparative QSAR Modeling of 4-Pyridones as Potent Antimalarials

    2010

    6 cites
  110. Exploring different classification-dependent QSAR modelling strategies for HDAC3 inhibitors in search of meaningful structural contributors

    2024

    View DOI
    5 cites
  111. Exploration of Fingerprints and Data Mining-based Prediction of Some Bioactive Compounds from Allium sativum as Histone Deacetylase 9 (HDAC9) Inhibitors

    2024

    View DOI
    5 cites
  112. Identification of structural fingerprints among natural inhibitors of HDAC1 to accelerate nature-inspired drug discovery in cancer epigenetics

    2023

    View DOI
    5 cites
  113. Host P2X7R-p38MAPK axis mediated intra-macrophage leishmanicidal activity of Spergulin-A

    2022

    View DOI
    5 cites
  114. QSAR for analogs of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides as antitumor agents

    2007

    5 cites
  115. Pharmacophore Mapping of Tricyclic Isoxazoles for Their Affinity Towards Alpha-2 Adrenoreceptors #

    2006

    5 cites
  116. Unveiling structural components of dibenzofuran-based MMP-12 inhibitors: a comparative classification-dependent analysis with molecular docking-based virtual screening and molecular dynamics simulation

    2025

    View DOI
    4 cites
  117. Chrysin-functionalized gold nanoparticles and paclitaxel exhibit synergistic impact on lung cancer cell lines via regulating the AKT/PPAR-ϒ/β-catenin pathway

    2024

    View DOI
    4 cites
  118. Exploring crucial structural attributes of quinolinyl methoxyphenyl sulphonyl-based hydroxamate derivatives as ADAM17 inhibitors through classification-dependent molecular modelling approaches

    2024

    View DOI
    4 cites
  119. Quasi-SMILES as a Tool for Peptide QSAR Modelling

    2023

    View DOI
    4 cites
  120. Dissecting the Drug Development Strategies Against SARS-CoV-2 Through Diverse Computational Modeling Techniques

    2020

    View DOI
    4 cites
  121. Evaluation of the antipyretic potential of methanol extract of the leaves of Abies spectabilis (D. Don) Spach.

    2007

    4 cites
  122. Microdontic maxillary lateral incisor: case report.

    1992

    4 cites
  123. A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment

    2023

    View DOI
    3 cites
  124. HDAC9 as a Privileged Target: Reviewing its Role in Different Diseasesand Structure-activity Relationships (SARs) of its Inhibitors

    2023

    View DOI
    3 cites
  125. Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors

    2021

    View DOI
    3 cites
  126. Structural findings of pyrazolo[1,5- a ]pyrimidine compounds for their Pim-1/2 kinase inhibition as potential anticancer agents

    2017

    3 cites
  127. Nitric Oxide Synthase (NOS) Inhibitors in Cancer Angiogenesis

    2015

    View DOI
    3 cites
  128. Search for Structural Requirements of 2-Phenylimidazo(1,2-. ) pyridineacetamide Analogs to Improve Affinity and Selectivity towards Central and/or Peripheral Benzodiazepine Receptors

    2007

    3 cites
  129. QSAR Study on Some Dihydrofolate Reductase Inhibitors

    2003

    3 cites
  130. Nitrogen-containing heterocycles as important scaffold for selective and potent HDAC8 inhibition: a step towards effective, non-toxic and selective HDAC8 inhibitor discovery

    2024

    View DOI
    2 cites
  131. 2D-QSAR Studies

    2023

    View DOI
    2 cites
  132. 3D-QSAR Studies

    2023

    View DOI
    2 cites
  133. In-house glutamine based compound loaded poly-(D-L-lactide-coglycolide) nanoparticles as a possible candidate for the management of chronic myeloid leukemia

    2023

    View DOI
    2 cites
  134. Exploring molecular fingerprints of different drugs having bile interaction: a stepping stone towards better drug delivery

    2023

    View DOI
    2 cites
  135. In Silico Discovery of Class IIb HDAC Inhibitors: The State of Art

    2023

    View DOI
    2 cites
  136. Predictive Quantitative Structure Toxicity Relationship Study on Avian Toxicity of Some Diverse Agrochemical Pesticides by Monte Carlo Method

    2016

    View DOI
    2 cites
  137. Axially-symmetric Neutron stars: Implication of rapid rotation

    2009

    View DOI
    2 cites
  138. Search for Potential Anticancer Agents: Evaluation of Anticancer Activity of Carcinosin, Apis and Thuja

    2008

    View DOI
    2 cites
  139. 1,5-N,N'-Disubstituted-2-(Substituted Benzenesulphonyl)- Glutamamide Analogues as Anticancer Agents. Part 3. † Synthesis, Biological Screening and QSAR Study #

    2005

    2 cites
  140. Potential energy surfaces forN =Z,20Ne-112Ba nuclei

    2004

    View DOI
    2 cites
  141. Development of Indomethacin- and Ibuprofen-loaded Polymethylmethacrylate Microparticles

    1996

    View DOI
    2 cites
  142. Arylcarboxamide Derivatives as Promising HDAC8 Inhibitors: An Overview in Light of Structure-activity Relationship and Binding Mode of Interaction Analysis

    2024

    View DOI
    1 cites
  143. Modeling Inhibitors of Gelatinases

    2023

    View DOI
    1 cites
  144. Other Modeling Approaches

    2023

    View DOI
    1 cites
  145. Establishing connection between neutron star properties and nuclear matter parameters through a comprehensive multivariate analysis

    2023

    View DOI
    1 cites
  146. Exploring Structural Requirements of Diarylurea Derivatives as VEGFR-2 Inhibitors Through Comparative QSAR Modeling Study

    2020

    1 cites
  147. First Report on the Validated Classification-Based Chemometric Modeling of Human Rhinovirus 3C Protease (HRV 3Cpro) Inhibitors

    2018

    View DOI
    1 cites
  148. Application of Computation in the Biosynthesis of Phytochemicals

    2018

    View DOI
    1 cites
  149. Epstein–Barr Virus and Treatment of Its Infection

    2014

    View DOI
    1 cites
  150. QSAR Study on Some Antirhino/Enteroviral Vinylacetylene Benzimidazoles

    2003

    1 cites
  151. QSAR Study on Some Substituted Glutamine Analogs as Anticancer Agents

    2003

    1 cites
  152. Modeling Inhibitors of Membrane-Type MMPs

    2023

    View DOI
    0 cites
  153. Conclusion and Future Perspectives

    2023

    View DOI
    0 cites
  154. Modeling Inhibitors of Other MMPs

    2023

    View DOI
    0 cites
  155. Modeling Inhibitors of Collagenases

    2023

    View DOI
    0 cites
  156. Membrane-Type MMPs and Their Inhibitors

    2023

    View DOI
    0 cites
  157. Other MMPs and Their Inhibitors

    2023

    View DOI
    0 cites
  158. Collagenases and Their Inhibitors

    2023

    View DOI
    0 cites
  159. Stromelysins and Their Inhibitors

    2023

    View DOI
    0 cites
  160. Gelatinases and Their Inhibitors

    2023

    View DOI
    0 cites
  161. Modeling Inhibitors of Stromelysins

    2023

    View DOI
    0 cites
  162. Matrilysin and Their Inhibitors

    2023

    View DOI
    0 cites
  163. Modeling Inhibitors of Matrilysin

    2023

    View DOI
    0 cites
  164. Exploring Structural Requirements of HDAC10 Inhibitors Through Comparative Machine Learning Approaches

    2023

    View DOI
    0 cites
  165. Host P2X &lt;sub&gt;7&lt;/sub&gt;R-P &lt;sub&gt;38&lt;/sub&gt;MAPK Axis Mediated Intra-Macrophage Leishmanicidal Activity of Spergulin-A

    2022

    View DOI
    0 cites
  166. Apoptosis Inducing Activity of Diospyros melanoxylon Bark Extract on Molt-3 Cell Line via Activation of Mitochondrial Membrane Caspase Cascade and Cell Cycle Arrest with its Antioxidant Potential

    2021

    View DOI
    0 cites
  167. Synthesis, biological evaluation, and enzyme assay of some 5-N-substituted-2-N- (arylsulphonyl)-L(+)glutamines as potential anticancer agents

    2020

    View DOI
    0 cites
  168. Innovation Strategies to Cope Up with Globalization: How to Market Digital Nomads

    2020

    0 cites
  169. A Comparative Multi-QSAR Modelling and Molecular Docking Studies of Some Arylsulfonamide-Based ADAM17 Inhibitors as Anticancer Agents

    2020

    0 cites
  170. Discriminations of Actives from Inactives HDAC8 Inhibitors: Molecular Modeling Study to Explore Essential Molecular Fingerprints

    2020

    0 cites
  171. Exploring the Structural Aspects of Ureido Amino Acid-Based APN Inhibitors through Validated Comparative Regression and Classification Based Molecular Modeling Studies

    2020

    0 cites
  172. Contributors

    2020

    View DOI
    0 cites
  173. Spergulin-A strives intra-macrophage leishmanicidal activity by regulating the host P2X <sub>7</sub> R-P <sub>38</sub> MAPK axis

    2019

    View DOI
    0 cites
  174. Impact of Magnetic field on neutron star properties

    2018

    View DOI
    0 cites
  175. Contributors

    2018

    View DOI
    0 cites
  176. Supplementary material : Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization

    2017

    0 cites
  177. Iconography : Homoisoflavonoids as potential antiangiogenic agents for retinal neovascularization

    2017

    0 cites
  178. Contributors

    2017

    View DOI
    0 cites
  179. Development of Nitric Oxide Synthase (NOS) Inhibitors for Cancer Angiogenesis

    2015

    View DOI
    0 cites
  180. Properties of Rotating Neutron Star

    2015

    View DOI
    0 cites
  181. At a More Integrative Level It Examines and Index the Organic Pathways and Organizations that are a Significant Piece of Frameworks Science

    2015

    0 cites
  182. SP HSP-Exploration of structural and physicochemical requirements and search of virtual hits of HSP90 inhibitors as potential anticancer agents

    2014

    0 cites
  183. The rotating frequency and GW strain amplitude from Nuclear Models

    2014

    0 cites
  184. C onstraints on nuclear m atter param eters ofan Eective C hiralM odel

    2013

    0 cites
  185. Impact of a light stabilized radion in supernovae cooling

    2012

    0 cites
  186. POSSIBLE ANTINEOPLASTIC AGENTS, PART XVI: SYNTHESIS, IN VIVO ANTITUMOR AND INVITRO ANTIANGIOGENIC STUDY OF FEW GLUTAMIC ACID ANALOGS

    2011

    0 cites
  187. `$f_0 (600)$' and chiral dynamics

    2009

    View DOI
    0 cites
  188. From nuclear matter to Neutron Stars

    2009

    View DOI
    0 cites
  189. Calibration of nuclear matter parameters in an eective chiral model

    2009

    0 cites
  190. Search for Potential Anticancer Agents

    2008

    0 cites
  191. Effect of Hyperons on Nuclear Equation of State and Neutron Star Structure

    2008

    0 cites
  192. The island of deformation and shape co-existence in neutron-deficient nuclei of the Pb region using relativistic mean field model

    2004

    View DOI
    0 cites
  193. Role of BCS-type pairing in light deformed nuclei: A relativistic mean field approach

    2003

    View DOI
    0 cites
  194. ChemInform Abstract: POSSIBLE ANTINEOPLASTIC AGENTS: PART VIII ‐ SYNTHESIS AND ANTINEOPLASTIC ACTIVITY OF 5‐N‐SUBSTITUTED 3‐P‐SUBSTITUTED‐PHENYLGLUTARAMIC ACIDS AND 5‐N‐SUBSTITUTED 2‐BENZENESULFONYL‐3‐PHENYL‐L‐GLUTAMINES

    1984

    View DOI
    0 cites
  195. Epstein-barr virus and treatment of its infection

    Cancer-Causing Viruses and their Inhibitors1970book chapter

    View DOI
    0 cites
  196. Massive neutron stars and their implications

    Pramana - Journal of Physics1970journal article

    View DOI
    0 cites
  197. Tsallis statistics and the role of a stabilized radion in the supernovae SN1987A cooling

    International Journal of Modern Physics A1970journal article

    View DOI
    0 cites
  198. Predictive comparative QSAR modeling of 4-pyridones as potent antimalarials

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  199. QSAR for analogs of 1,5-N,N'-disubstituted-2-(substituted benzenesulphonyl) glutamamides as antitumor agents

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  200. QSAR study on coumarins as antimeningoencephalitic agents

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  201. Possible antineoplastic agents, part XVI: Synthesis, In Vivo Antitumor and Invitro antiangiogenic study of few glutamic acid analogs

    International Journal of Pharmaceutical Sciences Review and Research1970journal article

    0 cites
  202. Predictive comparative QSAR modeling of 4-Pyridones as potent antimalarials

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  203. QSAR study on coumarins as antimeningoencephalitic agents

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  204. 0 cites
  205. Evaluation of the antipyretic potential of methanol extract of the leaves of Abies spectabilis (D. Don) Spach

    Indian Journal of Natural Products and Resources1970journal article

    0 cites
  206. QSAR for analogs of 1,5-N,N′-disubstituted-2-(substituted benzenesulphonyl) glutamamides as antitumor agents

    Internet Electronic Journal of Molecular Design1970journal article

    0 cites
  207. QSAR study on some synthesized and biologically evaluated glutamine analogs as possible anticancer agents

    Indian Journal of Chemistry - Section A Inorganic, Physical, Theoretical and Analytical Chemistry1970journal article

    0 cites
  208. Potential energy surfaces for N = Z, <sup>20</sup>Ne-<sup>112</sup>Ba nuclei

    Pramana - Journal of Physics1970journal article

    0 cites
  209. Enhanced regression of tumors in mice with combined chemotherapy and immunotherapy

    Indian Journal of Pharmacology1970journal article

    0 cites
  210. Effects of hadron-quark phase transition on properties of neutron stars

    Journal of Physics G: Nuclear and Particle Physics1970journal article

    View DOI
    0 cites
  211. Properties of Neutron stars with hyperon cores in parametrized hydrostatic conditions

    International Journal of Modern Physics E1970journal article

    View DOI
    0 cites
  212. Nitric oxide synthase (NOS) inhibitors in cancer angiogenesis

    Current Enzyme Inhibition1970journal article

    0 cites